Israeli pharmaceutical company Teva receives Chinese approval for new Huntington's treatment - Al-Monitor: Independent, trusted coverage of the Middle East
![S&P Global Ratings affirms Teva Pharmaceutical Industries at "BB-" (Local Currency LT credit rating); outlook stable S&P Global Ratings affirms Teva Pharmaceutical Industries at "BB-" (Local Currency LT credit rating); outlook stable](https://data.cbonds.com/organisations_logos/13739/1506089713teva.png)
S&P Global Ratings affirms Teva Pharmaceutical Industries at "BB-" (Local Currency LT credit rating); outlook stable
![In this photo illustration the Israeli multinational pharmaceutical company Teva Pharmaceutical Industries logo seen displayed on a smartphone with an economic stock exchange index graph in the background Stock Photo - Alamy In this photo illustration the Israeli multinational pharmaceutical company Teva Pharmaceutical Industries logo seen displayed on a smartphone with an economic stock exchange index graph in the background Stock Photo - Alamy](https://c8.alamy.com/comp/2HETMFC/in-this-photo-illustration-the-israeli-multinational-pharmaceutical-company-teva-pharmaceutical-industries-logo-seen-displayed-on-a-smartphone-with-an-economic-stock-exchange-index-graph-in-the-background-2HETMFC.jpg)
In this photo illustration the Israeli multinational pharmaceutical company Teva Pharmaceutical Industries logo seen displayed on a smartphone with an economic stock exchange index graph in the background Stock Photo - Alamy
![Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal](https://media.bizj.us/view/img/10278469/unknown-6*1200xx2016-1136-0-122.jpg)